{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:57:42Z","timestamp":1792929462816,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30OD030021"],"award-info":[{"award-number":["F30OD030021"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01CA254849"],"award-info":[{"award-number":["P01CA254849"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA237789"],"award-info":[{"award-number":["R21CA237789"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI163731"],"award-info":[{"award-number":["R21AI163731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI146009"],"award-info":[{"award-number":["R01AI146009"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA136393"],"award-info":[{"award-number":["P50CA136393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA268069"],"award-info":[{"award-number":["U54CA268069"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research and Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002039","name":"CURE Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000179","name":"Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000885","name":"Children&apos;s Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002086","name":"Fanconi Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ymthe.2024.04.024","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T11:24:34Z","timestamp":1713266674000},"page":"1817-1834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-5949","authenticated-orcid":false,"given":"Joseph G.","family":"Skeate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Pomeroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Slipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce J.","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Woong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walker S.","family":"Lahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Stelljes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobai","family":"Patrinostro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Zarecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"Bridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle M.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline D.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Leerar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari T.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathlyn M.","family":"Hornberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsti","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton","family":"Smedley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Largaespada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau R.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-3767","authenticated-orcid":false,"given":"Branden S.","family":"Moriarity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.04.024_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/138920210790886871","article-title":"DNA transposons: nature and applications in genomics","volume":"11","author":"Mu\u00f1oz-L\u00f3pez","year":"2010","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.ymthe.2024.04.024_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13287-021-02406-6","article-title":"Nonviral genome engineering of natural killer cells","volume":"12","author":"Robbins","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)80436-5","article-title":"Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells","volume":"91","author":"Ivics","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.04.024_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.mt.6300404","article-title":"Sleeping Beauty transposon-mediated engineering of human primary T\u00a0cells for therapy of CD19+ lymphoid malignancies","volume":"16","author":"Huang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib5","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ymthe.2005.06.484","article-title":"Hyperactive transposase mutants of the Sleeping Beauty transposon","volume":"12","author":"Baus","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mt.6300028","article-title":"PiggyBac transposon-mediated gene transfer in human cells","volume":"15","author":"Wilson","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13100-016-0062-z","article-title":"Active recombinant Tol2 transposase for gene transfer and gene discovery applications","volume":"7","author":"Ni","year":"2016","journal-title":"Mob. DNA"},{"key":"10.1016\/j.ymthe.2024.04.024_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/gt.2014.104","article-title":"The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies","volume":"22","author":"Tsukahara","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.04.024_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.04.024_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.04.024_bib12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.04.024_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.04.024_bib14","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1158\/0008-5472.CAN-09-0494","article-title":"Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors","volume":"69","author":"Bobisse","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.04.024_bib15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T\u00a0cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.04.024_bib16","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.04.024_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1182\/blood.V124.21.550.550","article-title":"Anti-CD19 CAR T Cells Administered after Low-Dose Chemotherapy Can Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma","volume":"124","author":"Kochenderfer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.04.024_bib18","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/leu.2008.219","article-title":"Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?","volume":"22","author":"Staal","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2024.04.024_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fped.2019.00443","article-title":"Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives","volume":"7","author":"Staal","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymthe.2024.04.024_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.04.024_bib21","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.04.024_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T\u00a0cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.04.024_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/mt.2016.11","article-title":"Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4(+) T Cells","volume":"24","author":"Gogol-D\u00f6ring","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib24","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.04.024_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1534\/genetics.111.126813","article-title":"Phylogenetic and functional characterization of the hAT transposon superfamily","volume":"188","author":"Arensburger","year":"2011","journal-title":"Genetics"},{"key":"10.1016\/j.ymthe.2024.04.024_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042666","article-title":"Comparative analysis of the recently discovered hAT transposon TcBuster in human cells","volume":"7","author":"Woodard","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.04.024_bib27","first-page":"E478","article-title":"A resurrected mammalian hAT transposable element and a closely related insect element are highly active in human cell culture","volume":"110","author":"Li","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.04.024_bib28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41467-018-03787-8","article-title":"Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in\u00a0vivo","volume":"9","author":"O\u2019Neil","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.04.024_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.omtm.2021.03.011","article-title":"Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype","volume":"21","author":"Nakamura","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.04.024_bib30","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1172\/JCI138473","article-title":"Sleeping Beauty-engineered CAR T\u00a0cells achieve antileukemic activity without severe toxicities","volume":"130","author":"Magnani","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.04.024_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ng.343","article-title":"Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates","volume":"41","author":"M\u00e1t\u00e9s","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.04.024_bib32","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1073\/pnas.1008322108","article-title":"A hyperactive piggyBac transposase for mammalian applications","volume":"108","author":"Yusa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.04.024_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.mie.2020.07.010","article-title":"Consensus Finder web tool to predict stabilizing substitutions in proteins","volume":"643","author":"Jones","year":"2020","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib34","doi-asserted-by":"crossref","first-page":"10747","DOI":"10.1073\/pnas.91.22.10747","article-title":"DNA shuffling by random fragmentation and reassembly: in\u00a0vitro recombination for molecular evolution","volume":"91","author":"Stemmer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.04.024_bib35","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/nar\/25.6.1307","article-title":"Optimization of DNA shuffling for high fidelity recombination","volume":"25","author":"Zhao","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.04.024_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-0556-2-6","article-title":"The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events","volume":"2","author":"Zhang","year":"2004","journal-title":"Genet. Vaccin. Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ymthe.2019.10.009","article-title":"A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy","volume":"28","author":"Pomeroy","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-023-01157-4","article-title":"Cas9-induced targeted integration of large DNA payloads in primary human T\u00a0cells via homology-mediated end-joining DNA repair","author":"Webber","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2024.04.024_bib39","series-title":"Pathologic Basis of Veterinary Disease","first-page":"73","article-title":"Chapter 3 - Inflammation and Healing1","author":"Ackermann","year":"2017"},{"key":"10.1016\/j.ymthe.2024.04.024_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-61779-352-3_11","article-title":"Generation of high-expressing cells by methotrexate amplification of destabilized dihydrofolate reductase selection marker","volume":"801","author":"Ng","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10565-009-9122-1","article-title":"Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells","volume":"26","author":"Affleck","year":"2010","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/gt.2012.97","article-title":"Efficient selection of genetically modified human T\u00a0cells using methotrexate-resistant human dihydrofolate reductase","volume":"20","author":"Jonnalagadda","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040952","article-title":"Natural Killer Cells: Tumor Surveillance and Signaling","volume":"12","author":"Meza Guzman","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ymthe.2024.04.024_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/bs.ircmb.2018.08.001","article-title":"Cancer Immunosurveillance by T Cells","volume":"342","author":"Rao","year":"2019","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib45","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1101\/gr.6286907","article-title":"HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications","volume":"17","author":"Wang","year":"2007","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2024.04.024_bib46","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e32832caf28","article-title":"HIV integration site distributions in resting and activated CD4+ T\u00a0cells infected in culture","volume":"23","author":"Brady","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ymthe.2024.04.024_bib47","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-020-19094-0","article-title":"Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells","volume":"11","author":"Mark","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.04.024_bib48","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1","article-title":"NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells","volume":"29","author":"Sivori","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib49","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.celrep.2014.05.011","article-title":"NK cell receptor NKp46 regulates graft-versus-host disease","volume":"7","author":"Ghadially","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.04.024_bib50","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2019.00719","article-title":"NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans","volume":"10","author":"Parodi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib51","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","article-title":"NKp44, a novel triggering surface\u00a0molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis","volume":"187","author":"Vitale","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.04.024_bib52","article-title":"FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T\u00a0cell Immunotherapies","year":"2023","journal-title":"US Food Drug Adm."},{"key":"10.1016\/j.ymthe.2024.04.024_bib53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tree.2010.06.001","article-title":"Promiscuous DNA: horizontal transfer of transposable elements and why it matters for eukaryotic evolution","volume":"25","author":"Schaack","year":"2010","journal-title":"Trends Ecol. Evol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/5997","article-title":"Taming of transposable elements by homology-dependent gene silencing","volume":"21","author":"Jensen","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.04.024_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/nar\/gkw1115","article-title":"Temporal self-regulation of transposition through host-independent transposase rodlet formation","volume":"45","author":"Woodard","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.04.024_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093064","article-title":"An efficient Screening System in Yeast to Select a Hyperactive piggyBac Transposase for Mammalian Applications","volume":"21","author":"Wen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.04.024_bib57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/hum.2017.136","article-title":"Efficient Non-Viral T-Cell Engineering by Sleeping Beauty Minicircles Diminishing DNA Toxicity and miRNAs Silencing the Endogenous T-Cell Receptors","volume":"29","author":"Clauss","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib58","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/CJI.0b013e3181ad762b","article-title":"Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes","volume":"32","author":"Nakazawa","year":"2009","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2024.04.024_bib59","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1080\/15384101.2018.1486164","article-title":"Modified ARCA analogs providing enhanced translational properties of capped mRNAs","volume":"17","author":"Kocmik","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ymthe.2024.04.024_bib60","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.omtm.2020.04.009","article-title":"Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus","volume":"17","author":"Suschak","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.04.024_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179749","article-title":"A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes","volume":"23","author":"Laoharawee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.04.024_bib62","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.04.024_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jim.2014.05.019","article-title":"Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs","volume":"409","author":"Garcia","year":"2014","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ymthe.2024.04.024_bib64","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1158\/0008-5472.CAN-07-5600","article-title":"Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system","volume":"68","author":"Singh","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.04.024_bib65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/gt.2011.40","article-title":"The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T\u00a0cells to express a chimeric antigen receptor","volume":"18","author":"Jin","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib66","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1172\/JCI86721","article-title":"Phase I trials using Sleeping Beauty to generate CD19-specific CAR T\u00a0cells","volume":"126","author":"Kebriaei","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.04.024_bib67","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood.2019002920","article-title":"Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas","volume":"135","author":"Srour","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.04.024_bib68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/hum.2018.218","article-title":"CAR T Cells Generated Using Sleeping Beauty Transposon Vectors and Expanded with an EBV-Transformed Lymphoblastoid Cell Line Display Antitumor Activity In\u00a0Vitro and In\u00a0Vivo","volume":"30","author":"Chicaybam","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2019.09.009","article-title":"PiggyBac-engineered T\u00a0cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma","volume":"225","author":"Wang","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.ymthe.2024.04.024_bib70","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.ymthe.2018.05.007","article-title":"PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts","volume":"26","author":"Bishop","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.04.024_bib71","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40425-018-0441-8","article-title":"Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells","volume":"6","author":"Wang","year":"2018","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.04.024_bib72","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41467-021-27853-w","article-title":"A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers","volume":"13","author":"Wong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.04.024_bib73","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jcyt.2022.07.008","article-title":"Concurrent transposon engineering and CRISPR\/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cells","volume":"24","author":"Gurney","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2024.04.024_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102712","article-title":"TIGIT Expression on Activated NK Cells Correlates with Greater Anti-Tumor Activity but Promotes Functional Decline upon Lung Cancer Exposure: Implications for Adoptive Cell Therapy and TIGIT-Targeted Therapies","volume":"15","author":"Hasan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ymthe.2024.04.024_bib75","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood.2020006619","article-title":"CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas","volume":"136","author":"Gang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.04.024_bib76","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.2020007748","article-title":"Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells","volume":"137","author":"Daher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.04.024_bib77","article-title":"Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies","volume":"14","author":"He","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib78","article-title":"Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities","volume":"9","author":"Christodoulou","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.04.024_bib79","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-022-02003-x","article-title":"KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape","volume":"28","author":"Li","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.04.024_bib80","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood-2014-02-556837","article-title":"Autonomous growth and increased cytotoxicity of\u00a0natural killer cells expressing membrane-bound interleukin-15","volume":"124","author":"Imamura","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.04.024_bib81","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.4049\/jimmunol.180.9.6392","article-title":"Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy","volume":"180","author":"Binyamin","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.04.024_bib82","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/s41591-022-02009-5","volume":"28","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.04.024_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030264","article-title":"Membrane-bound IL-21 promotes sustained ex\u00a0vivo proliferation of human natural killer cells","volume":"7","author":"Denman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.04.024_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185056","article-title":"BBMerge - Accurate paired shotgun read merging via overlap","volume":"12","author":"Bushnell","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.04.024_bib85","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"Embnet. J."},{"key":"10.1016\/j.ymthe.2024.04.024_bib86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/bioinformatics\/bty648","article-title":"Scaling read aligners to hundreds of threads on general-purpose processors","volume":"35","author":"Langmead","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.04.024_bib87","doi-asserted-by":"crossref","first-page":"D493","DOI":"10.1093\/nar\/gkh103","article-title":"The UCSC Table\u00a0Browser data retrieval tool","volume":"32","author":"Karolchik","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.04.024_bib88","article-title":"Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation","volume":"110","author":"Amend","year":"2016","journal-title":"J. Vis. Exp."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624002417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624002417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:25:39Z","timestamp":1776803139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624002417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1525001624002417"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.04.024","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}]}}